Seeing Is Believing
Currently out of the existing stock ratings of Michael Okunewitch, 1 are a HOLD (8.33%), 11 are a BUY (91.67%).
Analyst Michael Okunewitch, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 7.14% that have a potential upside of 28.15% achieved within 10 days.
Michael Okunewitch’s has documented 23 price targets and ratings displayed on 7 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on HCWB, HCW Biologics at 29-May-2025.
Analyst best performing recommendations are on ANEB (ANEBULO PHARMACEUTICALS).
The best stock recommendation documented was for ANEB (ANEBULO PHARMACEUTICALS) at 5/15/2025. The price target of $3 was fulfilled within 69 days with a profit of $1.99 (197.03%) receiving and performance score of 28.56.
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 13-Jul-2021
$14
$10.25 (273.33%)
$11
2 months 21 days ago
(22-Oct-2025)
0/5 (0%)
$8.36 (148.23%)
Buy
Since 18-Oct-2021
$15
$11.25 (300.00%)
$10
5 months 13 days ago
(30-Jul-2025)
0/5 (0%)
$11.53 (332.28%)
Buy
Since 13-Jul-2021
1 years 6 months 22 days ago
(21-Jun-2024)
0/1 (0%)
$26.23 (139.74%)
Buy
Since 13-Jul-2021
$9
$5.25 (140.00%)
2 years 8 months ago
(12-May-2023)
0/3 (0%)
$7.1 (373.68%)
Buy
2 years 9 months 15 days ago
(27-Mar-2023)
0/1 (0%)
$17.08 (114.48%)
What Year was the first public recommendation made by Michael Okunewitch?